Challenges in Solid Tumors and Other Cancers: An Interdisciplinary Approach

Professor Nima Rezaei gained his medical degree (MD) from Tehran University of Medical Sciences and subsequently obtained an MSc in Molecular and Genetic Medicine and a PhD in Clinical Immunology and Human Genetics from the University of Sheffield, UK. He also spent a short-term fellowship of Pediatric Clinical Immunology and Bone Marrow Transplantation in the Newcastle General Hospital.  Professor Rezaei is now the Full Professor of Immunology and Vice Dean of Research and Technologies, School of Medicine, Tehran University of Medical Sciences, and the co-founder and Head of the Research Center for Immunodeficiencies. He is also the Founder of Universal Scientific Education and Research Network (USERN). Prof. Rezaei has already been the Director of more than two hundred research projects and has designed and participated in several international collaborative projects. Prof. Rezaei is the editor, editorial assistant, or editorial board member of more than fifty international journals. He has edited more than one hundred international books, has presented more than a thousand lectures/posters in congresses/meetings, and has published more than 1,500 scientific papers in the international journals.

• Enhancing Treatment Efficacy for Aggressive Pediatric Bone Sarcomas: The Promise of Nano Drug Delivery.- Tumor-Nerve Interface: An Emerging Therapeutic Intervention Point for Solid Cancers.- Adoptive Cell Transfer for Solid Tumors.- Dendritic Cell Vaccines in Cancer Immunotherapy: Expanding Horizons for Solid And Non-Solid Tumors.- Chimeric Antigen Receptor (Car) T Cell Immunotherapy for Solid Tumors.- Immunogenic Effect of Modulated Electro-Hyperthermia (mEHT) in Solid Tumors.- TIME is critical for Oncolytic Viral Therapies Against Solid Cancers.- Apoptosis Resistance in Solid Tumours: A Potential Therapeutic Target in Gastric Carcinoma?.- Recent Development of Biopsy Techniques on Solid Tumor and Its Relevance in Solid Tumor Management.- Sarcomas: Genetics, Cytogenetics and Liquid Biopsy.- Next Generation of Antibody-Drug Conjugates for Breast Cancer.- Tumor Heterogeneity in Triple Negative Breast Cancer: Shedding Light on the Role of AKT and RUNX.- Herbal Medicine as a Complementary Therapy to Traditional Treatment for Breast Cancer.- The Use of Radiology Imaging in Monitoring Treatment Response to PD-1/PD-L1 Inhibitors in Head and Neck Squamous Cell Carcinomas.- An Overview on Pediatric Posterior Fossa Tumors: From Clinical Manifestations to Survival Analysis.- Immunotherapeutic Approaches in Glioblastoma.- Natural Compounds in Glioma Therapy.- Nanomaterials for the Treatment of Lung Cancer: The Role of Natural Products.- New Era Treatment Modalities for Hematologic Cancers.- Epigenetic Alterations in Multiple Myeloma and Potential Therapy Approaches.- Autocrine Vitamin D Metabolism Mediates Anti-Cancer Actions in Uterine Cervical Cancer.- Current Surgical and Medical Oncological Treatment Approaches in Metastatic Gastric Cancer.- The Role of Hepatopancreatoduodenectomy for the Treatment of Hilar Cholangiocarcinoma.- Laparoscopic Hepatectomy for Hepatocellular Carcinoma.- Hepatopancreatobiliary Surgery Patients and Outcomes: Impact of Mental Health.- The Impact of Molecular Mechanisms, Tumor Microenvironment and Total Neoadjuvant Therapy on Rectal Surgery.- Novel Immunotherapy Approaches in Colorectal Cancer.- The Role of Bacterial Dysbiosis and Genotoxin Production in Colorectal Cancer Development.